ironbark222 Posted November 2, 2017 Share Posted November 2, 2017 As your posts are always the same would it be possible for you to just post once a year. Life is tedious enough as it is. Link to comment Share on other sites More sharing options...
Clinhope Posted November 2, 2017 Share Posted November 2, 2017 Epimatic...what, you mean you donÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡Ãƒâہ¡ÃƒÆ’‚¬ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¾Ãƒâہ¡ÃƒÆ’‚¢t check this site 30 times a day?! Link to comment Share on other sites More sharing options...
Macquarie Posted November 2, 2017 Share Posted November 2, 2017 The rise in volume and share price Ian due to Florian Homms letter published yesterday. He said CUV has a potential of 1600%. Link to comment Share on other sites More sharing options...
Farleap11 Posted November 2, 2017 Share Posted November 2, 2017 Are you able to provide additional information eg link and or other information as to where a copy of the newsletter you refer to can be found? Link to comment Share on other sites More sharing options...
NewToCli Posted November 2, 2017 Share Posted November 2, 2017 You have to pay for it it's a monthly abo... he said Clinuvel is the most undervalued biotech ... but his predictions are a bit bullish in my view ... Link to comment Share on other sites More sharing options...
mrdax Posted November 2, 2017 Share Posted November 2, 2017 He said the potential is between 300% and 5000%, in a very long term. Link to comment Share on other sites More sharing options...
Macquarie Posted November 2, 2017 Share Posted November 2, 2017 For his letter see florianhommlongshort.de Another free source of his opinion: I did not receive the letter myself, the 1600% mentioned below are taken from CUV discussion on wallstreet-online.de Homm said some months ago that's he would cover CUV twice yearly until the stock is appropriately covered by some equity research company. Homms employer "Die Zweite Meinung GmbH" (The second opinion) is holding 25,000 shares of CUV but he is not he said. Fair enough? Link to comment Share on other sites More sharing options...
controvers Posted November 2, 2017 Share Posted November 2, 2017 Frankfurth http://en.boerse-frankfurt.de/stock/Clinuv...ceuticals-share SP ÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’‚¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¬5,05, highest ÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’‚¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¬5,08. Volume more the 78000! Up ÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’‚¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚¬0,05 US https://investorshub.advfn.com/Clinuvel-Pha...ls-CLVLY-17953/ Up $0,06 by the start bid/ask price $5,64 / $5,75 In other words there is great interest! It's up to cuv right now.. I find it very strange that CUV most of the time is a follower, follows the outcome of the SP of UR9 and CLVLY. Australia is the Homebase of Clinuvel, Am I right/. It should be the other way around! Why doesn't CUV do what it has to do? A reason more that Clinuvel get Real Nasdaq-listed, inevitable Link to comment Share on other sites More sharing options...
MrJones Posted November 2, 2017 Share Posted November 2, 2017 Such a rise on zero news to me is a classic pump and dump. Hope i'm wrong but just doesn't feel right. Jones Link to comment Share on other sites More sharing options...
PortugueseMan Posted November 2, 2017 Share Posted November 2, 2017 It's rising? I can live with that I guess... Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now